XTNT logo
Xtant Medical Holdings, Inc.(XTNT)
$0.42Stale · unknown old
Chart
Q4 2026 EPS Estimate
$-0.02
Nov 10, 2026 · Reports before open
Revenue Estimate
$26M
FY2026E EPS$0.03

Analyst Sentiment

Wall St. Consensus
Buy
5 analysts·Limited coverage
70
Score
4 Buy (80%)1 Hold (20%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
480%
Hold
120%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$1.00
+138.3%
Consensus
$1.00
+138.3%
Bull
$1.00
+138.3%
12-Month Target Range5 analysts
$1.00$1.00$1.00
Current $0.42Consensus
Current Price
$0.42
Upside to Consensus
$0.58

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+9.76%
EPS
FY2028
Rev+7.92%
EPS
FY2029
Rev+11.19%
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$100M$110M$119M$132M$143M
Low$100M$110M$116M$131M$142M
High$101M$111M$122M$133M$145M
EBITDA Avg$14M$6M$11M
Low$14M$6M$-22M
High$15M$7M$28M
EBIT Avg$10M$2M$7M
Low$9M$1M$-26M
High$10M$3M$24M
Net Income Avg$5M$-2M$2M
Low$4M$-2M$-30M
High$5M$-750,212$15M
EPS Avg$0.03$-0.01$-0.05
Low$0.03$-0.01$-0.20
High$0.03$-0.01$0.10
Analysts (Rev / EPS)2 / 22 / 22 / 21 / 1 /
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$26M$30M$26M$27M$27M$30M$27M$28M
Low$26M$30M$25M$26M$27M$30M$27M$28M
High$26M$31M$26M$27M$28M$31M$27M$28M
EBITDA Avg$-2M$-248,758$-2M$-2M$-220,898$-207,471$-198,979$-189,674
Low$-2M$-271,160$-2M$-2M$-243,300$-229,873$-221,381$-212,076
High$-2M$-226,356$-2M$-2M$-198,496$-185,069$-176,577$-167,272
EBIT Avg$-2M$-782,919$-2M$-2M$-782,919$-782,919$-782,919$-782,919
Low$-2M$-805,321$-2M$-2M$-805,321$-805,321$-805,321$-805,321
High$-2M$-760,517$-2M$-2M$-760,517$-760,517$-760,517$-760,517
Net Income Avg$-3M$-1M$-3M$-3M$-1M$-1M$-1M$-1M
Low$-3M$-1M$-3M$-3M$-1M$-1M$-1M$-1M
High$-3M$-1M$-3M$-3M$-1M$-1M$-1M$-1M
EPS Avg$-0.02$-0.01$-0.02$-0.02$-0.01$-0.01$-0.01$-0.01
Low$-0.02$-0.01$-0.02$-0.02$-0.01$-0.01$-0.01$-0.01
High$-0.02$-0.01$-0.02$-0.02$-0.01$-0.01$-0.01$-0.01
Analysts (Rev / EPS)2 / 22 / 21 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Sep 2, 2026Loop Capital Markets
Lucid Capital Markets Starts Xtant Medical (XTNT) at Buy
Target:$1.00
+171.7%from $0.37
Oct 18, 2024Craig-Hallum
Xtant Medical (XTNT) PT Lowered to $1.50 at Craig-Hallum
Target:$1.50
+168.8%from $0.56
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.